3-rd International Conference on
September 5-7 2017
The 3rd International Conference on the FMR1 Premutation welcomes the submission of abstracts for original contribution to the field in the following:
Abstracts submitted should contain concise statements of:
The abstract text body is limited to 400 words including the title. Titles are limited to 25 words.
One table can be included, with maximum 7 rows and 10 columns.
After submission, a confirmation email will be sent to the submitter. In order to receive confirmation, please ensure that emails from Shai.firstname.lastname@example.org and Yoram.email@example.com are not marked as spam by your e-mail provider.
Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.
The conference organizers regard plagiarism as serious professional misconduct. If plagiarism is identified, the abstract and any other abstracts submitted by the same author are rejected.
All submitted abstracts will go through a peer-review process carried out by an international reviewing committee. The 3rd International Conference on the FMR1 Premutation scientific committee uses abstract scores and rankings to develop the final congress program and select abstracts for oral or poster presentation.
The highest-scoring abstracts will be selected for presentation in oral presentation sessions; the other accepted abstracts will be displayed in the Poster Exhibition.
Notification of acceptance or rejection will be sent to the submitting (corresponding) author. Please note that only the corresponding author will receive an email concerning the status and is responsible for informing all co-authors. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract. If an author is invited to present and does not confirm their participation, the abstract will be withdrawn.
The submission of the abstracts constitutes the authors’ consent to publication. All abstracts accepted for presentation will be published in the Abstract supplement of The 3rd International Conference on the FMR1 Premutation.